A CDMO relationship rarely becomes a supply-chain problem overnight. More often, the warning signs appear gradually: timetables slip, your contact point changes, or issues start recurring.

Individual events are manageable, but patterns of operational friction can indicate that a CDMO is becoming a supply risk.

Here are five signs it may be time to take a closer look at your supply relationship.

Signs of CDMOs becoming a risk

  1. Everything is taking longer. Are change controls taking longer to complete? Are batch release dates becoming less predictable?

    When routine activities consistently take more time than they once did, it can be a sign that a CDMO's quality, technical or manufacturing resources are under increasing pressure.

    Delayed change controls can slow process improvements, packaging changes and other activities needed to maintain a commercial product. Drifting batch release schedules can force companies to carry additional inventory, adjust distribution plans or operate with increasingly narrow supply buffers.

    One delay may be an isolated event. A pattern deserves some scrutiny.

  2. Your key contacts keep changing. Turnover is inevitable in any organization. But frequent changes among project management, technical or quality personnel can make continued smooth operations impossible.

    Multiple changes risks the loss of institutional knowledge. Every handoff creates an opportunity for information to be lost or communication to break down. Sponsors should pay attention when they repeatedly have to explain their product, process history or priorities to new contacts.

    A stable team that understands your product can be an important part of supply continuity.

  3. Capacity conversations are becoming harder. Is your CDMO suddenly less flexible about production schedules? Are future capacity commitments becoming difficult to secure? Are forecast changes met with resistance rather than a collaborative planning discussion?

    These can be signs that a facility is operating close to its practical capacity.

    A strong manufacturing partner should be able to discuss capacity proactively and work with sponsors to plan for changes in demand rather than simply reacting when problems arise.

  4. Minor deviations are becoming a pattern. Repeated minor deviations deserve attention. When similar issues continue to appear, sponsors should ask whether there is an underlying problem with equipment, processes, training, maintenance or quality oversight.

    Every CDMO should be able to close individual deviations, but when recurring issues surface, your partner needs to be able to identify the cause, demonstrate that it's being addressed, and verify they will not eventually affect supply.

  5. Getting access to the site is becoming difficult. Especially when any of the above risks arise, your manufacturing partner should provide appropriate visibility into the operations supporting your product.

    If site visits are increasingly difficult to arrange, access to operational leadership is limited, or questions about manufacturing activities are met with delays or incomplete answers, that lack of transparency can become a risk in itself.

    Site access gives sponsors an opportunity to understand how their products are being manufactured, build relationships with the teams responsible for supply and identify potential issues before they become disruptions. In short, it provides reassurance and ensures trust is well-placed.

Is it time for a change? Don't wait for a supply disruption.

When multiple, recurring warning signs begin appearing together, a major supply disruption could be around the corner.

You should expect from your CDMO responsiveness, transparency, quality discipline and the flexibility to support your product as requirements change. If your current partnership is showing signs of becoming a supply risk, it may be time to evaluate your alternatives.

 

Talk to UPM Pharmaceuticals about building a safer, more responsive supply chain partnership.